Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an update.
Medical City Dallas Hospital has adopted Perimeter Medical Imaging AI’s S-Series OCT technology for high-resolution tissue visualization during surgeries. This adoption follows the hospital’s participation in a pivotal trial of Perimeter’s B-Series device, which integrates AI and is under FDA evaluation for breast-conserving surgeries. The S-Series OCT, cleared by the FDA in 2021, offers cellular-level imaging, making it ideal for surgical margin visualization. This deployment marks a significant step in Perimeter’s nationwide technology rollout, potentially enhancing surgical outcomes and positioning the company as a leader in advanced medical imaging solutions.
The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
Perimeter Medical Imaging AI is positioned in a growth phase with strong revenue increases and promising clinical advancements towards FDA approval. However, persistent net losses, cash flow constraints, and bearish technical indicators pose significant challenges. The valuation remains unattractive, but recent strategic corporate events offer potential for future expansion.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a medical technology company based in Toronto, Canada, and Dallas, Texas. It focuses on transforming cancer surgery with ultra-high-resolution, real-time imaging tools to address unmet medical needs. The company’s FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. Their next-generation Perimeter B-Series OCT with ImgAssist AI, supported by a significant grant, is under evaluation for breast-conserving surgeries.
Average Trading Volume: 136,358
Technical Sentiment Signal: Sell
Current Market Cap: C$23.38M
Find detailed analytics on PINK stock on TipRanks’ Stock Analysis page.